Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Structure enabled design of BAZ2-ICR
InChi: InChI=1S/C18H18N2O4/c21-15(19-24)10-2-1-3-11-20-17(22)13-8-4-6-12-7-5-9-14(16(12)13)18(20)23/h4-9
InChiKey: XLOXSIKLUAMDGU-RCCKNPSSSA-N
GSK0660 antagonizes 100% of the activity of PPARβ/δ with a pIC50 of 6
Darunavir - CAS# 206361-99-1 Catalog No.:M10170-10 Structure enabled design of BAZ2-ICRDarunavir is a drug used to treat HIV infection. It is in the protease inhibitor class. Prezista is an OARAC recommended treatment option for treatment nave and treatment experienced adults and adolescents. Developed by pharmaceutical company Tibotec, darunavir is named after Arun K. Ghosh, the chemist who discovered the molecule at the University of Illinois at Chicago. It was approved by the Food and Drug Administration (FDA) on June 23, 2006. .
US$ 52.00
US$ 1374.50
US$ 949.00
US$ 22.00
US$ 48.00
US$ 15.00
US$ 1199.50
US$ 2036.50
US$ 52.00